David I Finkelstein is the head of the Parkinson’s Disease Laboratory at the Florey Institute of Neuroscience and Mental Health. He is a Physiologist and neurobiologist. In this role, he uses his skills and knowledge to investigate possible new medical interventions for Parkinson’s. He received a BSc (1979 from LaTrobe University, Melbourne, Australia), MSc (1986), and PhD in Physiology (1991) from Monash University, Australia. He is Chair of Parkinson’s Victoria and advocates for more funding from government grants for Parkinson’s research and support for Parkinson’s services. His research investigates the neurobiology of neurodegeneration with particular emphasis on the processes that occur during Parkinson’s Disease. He is a scientific consultant for two biotechnology companies producing and developing novel small molecules for treating neurodegenerative diseases (Parkinson’s, Alzheimer’s, and Huntington’s Diseases). He is an editor and a reviewer for many international journals and granting bodies.